article thumbnail

Navigating CVS’s New Pricing Models: What to Know About CVS CostVantage and CVS Caremark TrueCost

Digital Pharmacist

CVS Health recently announced two new pricing models launching in 2025—CVS CostVantage (Focused on CVS as the Provider) and CVS Caremark TrueCost (Focused on CVS as the Payer)—which are intended to “drive aligned incentives and deliver a more transparent and sustainable reimbursement model” according to CVS Health’s press release. Fein, Ph.D.,

article thumbnail

DIR Fee Changes Coming in 2024: The Pros and Cons for Independent Pharmacies

Digital Pharmacist

DIR Fees: An Overview DIR fees, or Direct and Indirect Remuneration fees, are fees paid by pharmacies to PBMs. These fees are based on a variety of factors, including performance metrics and drug prices, and are typically calculated retroactively.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Happy 20th Birthday, Medicare Part D!

Integra X Files

Future of Part D As we observe the 20 th anniversary of the Medicare drug benefit, a recent survey shows overwhelming satisfaction with the value of the program among seniors. They have an incentive to keep prices as low as possible. The looming problem is how Medicare will contend with rising drug prices.

article thumbnail

Understanding Recent Changes to 505(b)(2) Drugs and Reimbursement

Pharmacy Times

This pathway’s expanded use and shifting Centers for Medicare & Medicaid Services (CMS) policies are reshaping reimbursement practices and therapeutic equivalence standards for 505(b)(2) drugs.

article thumbnail

Do We Really Pay More for Prescription Drugs in the United States?

Pharmacy Times

Trump signed an executive order titled “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients,” with the objective of lowering drug prices, namely on branded drug products, for American consumers. How Does Drug Pricing in the US Compare With Other Countries? REFERENCES 1.

article thumbnail

Pharmacy Policy Updates for June 2025

Pharmacy Times

According to Trump, patients could see cost reductions of 30% to 80%, but experts question the feasibility and practicality of implementing such a policy within the complex United States drug pricing and supply system. Kennedy Jr, is permitted to develop a new rule that ties American drug prices to those of other nations.